Arthrosamid logo

Getting your patients moving again

Join our symposium at the BOA 2021 Annual Congress

An estimated 5.6 million patients in the UK suffer with knee OA, but not all are suitable for surgery, creating a growing need for non-surgical treatments.

Come and find out more about a new non-degradable viscoelastic hydrogel - Arthrosamid®


BOA Conference Suite 4, BOA Annual Congress 2021


Tuesday 21st September form 17:45


17:45 – 18:00

Arrivals with drinks reception

18:00 - 18:30


What are the limitations to treat the fastest growing cause of disabilities worldwide?

The history of iPAAG – Novel therapy to treat patients with knee OA

Years of experience in using iPAAG and the benefits I can see for my patients with knee OA

Arthrosamid® Symposium

Let us know if you’d like to attend in person or recieve the recording after the event.